BR0205932A - Método e composição para tratamento de hipertensão ocular e glaucoma - Google Patents

Método e composição para tratamento de hipertensão ocular e glaucoma

Info

Publication number
BR0205932A
BR0205932A BR0205932-0A BR0205932A BR0205932A BR 0205932 A BR0205932 A BR 0205932A BR 0205932 A BR0205932 A BR 0205932A BR 0205932 A BR0205932 A BR 0205932A
Authority
BR
Brazil
Prior art keywords
treatment
glaucoma
composition
ocular hypertension
day
Prior art date
Application number
BR0205932-0A
Other languages
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0205932A publication Critical patent/BR0205932A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"MéTODO E COMPOSIçãO PARA TRATAMENTO DE HIPERTENSãO OCULAR E GLAUCOMA". é proporcionado um método para o tratamento de hipertensão ocular e glaucoma o qual compreende a administração de uma quantidade eficaz de um composto de 15-ceto-prostaglandina tendo uma estrutura em anel ao final da cadeia <sym> aos olhos de um indivíduo mamífero que precise de tal tratamento uma vez ao dia. De acordo com o método, uma única administração do composto diminui eficazmente a IOP do indivíduo no decorrer do dia.
BR0205932-0A 2001-08-23 2002-08-22 Método e composição para tratamento de hipertensão ocular e glaucoma BR0205932A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31411001P 2001-08-23 2001-08-23
PCT/JP2002/008446 WO2003018025A1 (en) 2001-08-23 2002-08-22 Method and composition for treatment of ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
BR0205932A true BR0205932A (pt) 2004-02-17

Family

ID=23218598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0205932-0A BR0205932A (pt) 2001-08-23 2002-08-22 Método e composição para tratamento de hipertensão ocular e glaucoma

Country Status (12)

Country Link
US (1) US20030060511A1 (pt)
EP (1) EP1420793A1 (pt)
JP (1) JP2004521960A (pt)
KR (1) KR20040029012A (pt)
CN (1) CN1575178A (pt)
AR (1) AR036276A1 (pt)
BR (1) BR0205932A (pt)
CA (1) CA2458230A1 (pt)
MX (1) MXPA04001604A (pt)
NO (1) NO20031779L (pt)
WO (1) WO2003018025A1 (pt)
ZA (1) ZA200302911B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8889735B2 (en) 2011-04-07 2014-11-18 Sucampo Ag Method for treating asthenopia

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932389A (en) * 1974-12-11 1976-01-13 Pfizer Inc. 2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
DE03014533T1 (de) * 1988-09-06 2004-07-15 Pharmacia Ab Prostaglandinderivative zur Behandlung von Glaukom oder okuläre Hypertension
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE111736T1 (de) * 1988-10-01 1994-10-15 R Tech Ueno Ltd Okulare hypotensive mittel.
US5194429A (en) * 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
ES2067864T3 (es) * 1990-05-22 1995-04-01 R Tech Ueno Ltd Tratamiento de la hipertension ocular con una combinacion sinergica para administracion ocular.
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
AU687906B2 (en) * 1993-12-15 1998-03-05 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
WO1997023225A1 (en) * 1995-12-22 1997-07-03 Alcon Laboratories, Inc. Combinations of dp and fp type prostaglandins for lowering iop
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
EP1420793A1 (en) 2004-05-26
ZA200302911B (en) 2003-10-14
AR036276A1 (es) 2004-08-25
NO20031779D0 (no) 2003-04-22
WO2003018025A1 (en) 2003-03-06
CN1575178A (zh) 2005-02-02
MXPA04001604A (es) 2004-07-08
CA2458230A1 (en) 2003-03-06
JP2004521960A (ja) 2004-07-22
US20030060511A1 (en) 2003-03-27
NO20031779L (no) 2003-04-22
KR20040029012A (ko) 2004-04-03

Similar Documents

Publication Publication Date Title
TWI255713B (en) Method for treating meibomian gland disease
EP0777483B1 (en) Methods and means for drug administration
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
KR930001913A (ko) 안염 치료방법
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
ATE119776T1 (de) Den augeninnendruck vermindernde 11- acylprostaglandine.
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia.
HK1061975A1 (en) Novel method and compostions for local treatment of meniere&#39;s disease, tinnitus and/or hearing loss
KR960033452A (ko) 시신경 질환의 치료를 위한 프로스타노산 화합물
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
BR9913955A (pt) Composição oftalmológica confortável e de liberação sustentada e método para terapia ocular
KR940003564A (ko) 특정 질환의 예방 및 치료용 약제를 제조하기 위한 c1- 불활성제화제의 용도
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
BR0205932A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
ATE326972T1 (de) Heilende zusammensetzung für intraokulare hypertension oder glaukom
BR0211545A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
BR0209601A (pt) Método para o tratamento da hipertensão ocular e do glaucoma
KR910019621A (ko) 상승병용을 이용한 안고혈압 치료
ES2170807T3 (es) Uso de prostaglandinas para la fabricacion de un medicamento para la prevencion y el tratamiento de catarata secundaria.
DE69829227D1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
CA2402597A1 (en) Composition for use in treatment of ocular hypertension and glaucoma
BR0317247A (pt) Dispositivo para aplicação ocular de princìpios ativos por via transpalpebral
AR007230A1 (es) El uso de brinzolamida para preparar un medicamento para prevenir o retardar la perdida del campo visual asociada con el glaucoma o hipertensionocular.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]